IBEX reports record Q2 revenue $164.2M (+17% YoY), raises FY revenue & EBITDA guidance

IBEX Ltd

2026-Q2 EPS reported $1.65 revenue$315,400,000

Q2 revenue $164.2M (+16.7% YoY); net income $12.2M; diluted EPS $0.83 (+45% YoY).
Adjusted EBITDA $20.7M (+25.2% YoY); adjusted EPS $0.87 (+46% YoY).
Raises FY2026 revenue guidance to $620-630M (from $605-620M) and adjusted EBITDA to $80-82M (from $78-81M).
HealthTech revenue grew 35.1% YoY; repurchased 78,200 shares for $2.9M during quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.